Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

AuroMedics Pharma LLC: Piperacillin and Tazobactam for Injection Recalled for Glass Particles

Agency Publication Date: May 16, 2018
Share:
Sign in to monitor this recall

Summary

AuroMedics Pharma LLC has recalled 77,400 vials of Piperacillin and Tazobactam for Injection, USP 3.375 grams. This prescription antibiotic is used for intravenous treatment but was found to contain visible glass particles following a customer report. If you have this medication, you should immediately contact your healthcare provider or pharmacist for guidance on how to safely return the product and obtain a replacement.

Risk

Injecting a product containing glass particles can cause serious health issues, including local irritation, inflammation, or more severe complications such as the blockage of blood vessels or damage to vital organs if the particles travel through the bloodstream.

What You Should Do

  1. Check your medication vials to see if they are Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial (NDC 55150-120-30).
  2. Verify the lot numbers and expiration dates on the vial labels: look for lot numbers PP0317061-A or PP0317049-A with an expiration date of August 2019.
  3. If your vials match these lot numbers, do not use the medication. Contact your healthcare provider or pharmacist immediately to discuss alternative treatments and to report the affected product.
  4. Return any unused vials to your pharmacy or the place of purchase for a full refund.
  5. Contact AuroMedics Pharma LLC at their East Windsor, New Jersey location for further instructions regarding the return process.
  6. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund
How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial
Model:
NDC 55150-120-30
Recall #: D-0926-2018
Lot Numbers:
PP0317061-A (Exp August 2019)
PP0317049-A (Exp August 2019)
Date Ranges: Expiration August 2019

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 79995
Status: Resolved
Manufacturer: AuroMedics Pharma LLC
Manufactured In: United States
Units Affected: 77,400 vials
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.